Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report

Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report

Malignant pleural mesothelioma (MPM) is an aggressive disease with poor prognosis and the current treatment for early-stage MPM is based on a multimodality therapy regimen involving platinum-based chemotherapy preceding or following surgery. To enhance the cytoreductive role of surgery, some peri- o...

Full description

Bibliographic Details
Main Authors:	Stefano Bongiolatti, Francesca Mazzoni, Ottavia Salimbene, Enrico Caliman, Carlo Ammatuna, Camilla E. Comin, Lorenzo Antonuzzo, Luca Voltolini
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Journal of Clinical Medicine
Subjects:	epithelioid malignant pleural mesothelioma pleurectomy and decortication hyperthermic intraoperative thoracic chemotherapy overall survival disease-free survival progression-free survival
Online Access:	https://www.mdpi.com/2077-0383/10/23/5542

Similar Items

Strategies to reduce morbidity following pleurectomy and decortication for malignant pleural mesothelioma
by: Patrick Bou‐Samra, et al.
Published: (2023-09-01)

Extended pleurectomy/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesotheliomaCentral MessagePerspective
by: Kenichi Okubo, MD, PhD, et al.
Published: (2023-12-01)

Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study
by: Marcello Migliore, et al.
Published: (2023-06-01)

Non‐incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgery
by: Kentaro Miura, et al.
Published: (2022-01-01)

Systematic Review and Meta-Analysis of Pleurectomy/Decortication versus Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma
by: Federica Danuzzo, et al.
Published: (2022-09-01)

Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
by: Giuseppe Mangiameli, et al.
Published: (2021-10-01)

VATS Pleurectomy Decortication Is a Reasonable Alternative for Higher Risk Patients in the Management of Malignant Pleural Mesothelioma: An Analysis of Short-Term Outcomes
by: Dong-Seok Lee, et al.
Published: (2021-03-01)

Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China
by: Bing Wang, et al.
Published: (2024-01-01)

Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis
by: Qiwen Wu, et al.
Published: (2019-01-01)

A case of attempted transbronchial spigot insertion for fistulous pyothorax in the residual pleural airspace after pleurectomy/decortication for malignant pleural mesothelioma
by: Ryo Miyata, et al.
Published: (2024-01-01)

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma
by: Robert A. Belderbos, MD, et al.
Published: (2021-04-01)

Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma
by: Viktor Proesmans, et al.
Published: (2022-12-01)

Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review
by: Jean-Marc Classe, et al.
Published: (2021-12-01)

Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study
by: Antoni Llueca, et al.
Published: (2023-08-01)

Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis
by: Yu Xia, et al.
Published: (2023-12-01)

Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis
by: Maria Llueca, et al.
Published: (2023-01-01)

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience
by: Francesco Falanga, et al.
Published: (2022-10-01)

Subtotal Pleurectomy with Intrathoracic Chemo Hyperthermia (HITHOC) for IVa Thymomas: De Novo Versus Recurrent Pleural Disease
by: Benjamin Chappuy, et al.
Published: (2022-10-01)

Follow-up for More than 10 Years of Patients with Peritoneal Metastases Treated with Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy in a Specialized Unit
by: Alba Fernández-Candela, et al.
Published: (2024-01-01)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers
by: Pei-Qi Lim, et al.
Published: (2022-09-01)

Association between pelvic exenteration and hyperthermic intraperitoneal chemotherapy for rectal cancer
by: Nicolae Bacalbasa, et al.
Published: (2021-06-01)

The Effects of Preserving the Diaphragm on Early and Late Outcome of Lung-Sparing Radical Surgery for Malignant Pleural Mesothelioma
by: Michelle Lee, et al.
Published: (2022-11-01)

Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study
by: Mingchen Ba, et al.
Published: (2019-12-01)

Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study
by: Guido Alberto Massimo Tiberio, et al.
Published: (2020-04-01)

Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis
by: Qin Tang, et al.
Published: (2023-01-01)

Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial
by: Maneesh Kumarsing Beeharry, et al.
Published: (2020-03-01)

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: JAIRO SEBASTIÁN ASTUDILLO VALLEJO, et al.
Published: (2023-04-01)

Video-assisted subtotal parietal pleurectomy: an effective procedure for recurrent refractory pneumothorax
by: Haomin Cai, et al.
Published: (2022-05-01)

Should Lung-Sparing Surgery Be the Standard Procedure for Malignant Pleural Mesothelioma?
by: Yoshinobu Ichiki, et al.
Published: (2020-07-01)

Efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer
by: SUN Qi, HUANG Wenbo, HE Bingliang, LIU Chang, XU Yuhang, ZHAO Wei
Published: (2023-07-01)

Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience
by: Cheng Ernest, et al.
Published: (2023-04-01)

Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
by: Xin Zhao, et al.
Published: (2023-02-01)

Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort
by: Irena Conic, et al.
Published: (2022-04-01)

Comparison of PFS-OS between two treatment methods (surgery and then chemotherapy compared with neoadjuvant and then surgery) in patients with endometrial cancer: a retrospective study
by: Narjes Afrooz, et al.
Published: (2023-01-01)

Successful lung-sparing resection of synchronous pleural mesothelioma and contralateral lung cancer
by: Naoko Imanishi, et al.
Published: (2017-05-01)

A Trimodality, Four-Step Treatment including Chemotherapy, Pleurectomy/Decortication and Radiotherapy in Early-Stage Malignant Pleural Mesothelioma: A Single-Institution Retrospective Case Series Study
by: Giovanni Vicidomini, et al.
Published: (2021-12-01)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
by: Bhaskar C. Kolla, et al.
Published: (2020-05-01)

Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
by: Yan-Dong Su, et al.
Published: (2023-12-01)

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
by: Bianca Varzaru, et al.
Published: (2023-07-01)

Chemotherapy alone versus chemotherapy plus 125I brachytherapy for the second-line treatment of locally recurrent cervical cancer after/with radical treatment: A propensity score analysis
by: Zhimei Huang, et al.
Published: (2024-01-01)